Bridging the Gap Between Participants and Clinical Trials
CPX101-Ⅱ-01 Obese Subjects without Diabetes Mellitus
CONDITION
Metabolic and Endocrine
GENDER
All
AGE GROUP
From 18
to 75 years
STATUS
Active, not recruiting
A Randomized, Double-blind, Placebo-controlled, Parallel-group Multicenter Trial to Evaluate the Safety and Efficacy of CPX101 in Overweight and Obese Subjects without Diabetes Mellitus